FOXO Technologies (FOXO) Stock Price, News & Analysis

Company Overview

FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.

Key Stats

• Today's Range: $0.20 to $0.21
• 50-Day Range: $0.13 to $0.93
• 52-Week Range: $0.13 to $1.30
• Volume: 783,615 shs
• Average Volume: 2.23 million shs
• Market Capitalization: $3.58 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

FOXO Stock Analysis - Frequently Asked Questions

When did FOXO Technologies' stock split?

FOXO Technologies's stock reverse split on Tuesday, November 7th 2023. The 1-10 reverse split was announced on Tuesday, November 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, November 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Who are FOXO Technologies' major shareholders?

FOXO Technologies' top institutional shareholders include Jane Street Group LLC (0.67%). Insiders that own company stock include Vincent J Dowling Jr and Kr8 Ai Inc.
View institutional ownership trends.

How do I buy shares of FOXO Technologies?

Shares of FOXO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 2/22/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Business Services
• Industry: Commercial physical research
• Sub-Industry: Business Services
• Current Symbol: NYSEAMERICAN:FOXO
• Previous Symbol: NYSE:FOXO
• CUSIP: N/A
• CIK: 1812360
• Web: technologies.com
• Phone: 612-562-9447
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-26,450,000.00
• Net Margins: -706.34%
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -56.49%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.08
• Quick Ratio: 0.08

Sales & Book Value

• Annual Sales: $140,000.00
• Price / Sales: 25.60
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($1.58) per share
• Price / Book: -0.13

Miscellaneous

• Outstanding Shares: 17,480,000
• Free Float: 16,191,000
• Market Cap: $3.58 million
• Optionable: Not Optionable
• Beta: 3.46